STIM logo

STIM Neuronetics, Inc.

NASDAQ Global Market · Medical - Devices · Healthcare

$1.25
+0.01 (+0.81%)

Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option …

Market Cap: $97.16Mwww.neurostar.com

Price

No data yet.

Social Signal Score

60
5d
58
2 mentions
—
30d
60
8 mentions
—
60d
61
9 mentions
—
90d
62
10 mentions
—
news: 10

Analyst Ratings

8 analysts
Buyconsensus
Strong Buy 0Buy 7Hold 1Sell 0Strong Sell 0
Avg price target$5+300.0%
Low $5Median $5High $5
Current Consensus

Revenue

$41.96M+457.56%
$7.53M$19.00M$30.48M$41.96M
Mar 2017Sep 2026

Analyst Estimates

FY2025
$-0.59
$-0.60–$-0.59
1 analysts
FY2026
$-0.29
$-0.29–$-0.29
2 analysts
FY2027
$-0.23
$-0.27–$-0.18
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Daniel L. Reuvers
Sector
Healthcare
Industry
Medical - Devices
Employees
658
Beta
1.20
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
-3.43
www.neurostar.com